Breast Biopsy Recommendations and Breast Cancers Diagnosed during the COVID-19 Pandemic

Kathryn P Lowry1, Michael C S Bissell1, Diana L Miglioretti1

  • 1From the Department of Radiology, University of Washington, Seattle Cancer Care Alliance, 1144 Eastlake Ave E, LG-215, Seattle, WA 98109 (K.P.L.); Division of Biostatistics, Department of Public Health Sciences, University of California Davis, Davis, Calif (M.C.S.B., D.L.M.); Kaiser Permanente Washington Health Research Institute, Kaiser Permanente Washington, Seattle, Wash (D.L.M., E.J.A.B., D.S.M.B., K.J.W.); Departments of Medicine and Epidemiology and Biostatistics, University of California, San Francisco, Calif (K.K.); Advocate Aurora Health, Downers Grove, Ill (N.A., T.M.); The Dartmouth Institute for Health Policy and Clinical Practice and Norris Cotton Cancer Center, Geisel School of Medicine at Dartmouth, Lebanon, NH (A.N.A.T.); Department of Radiology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC (L.H.); Department of Radiology (S.D.H., B.L.S.), University of Vermont Cancer Center (S.D.H., D.L.W., B.L.S.), Department of Pathology and Laboratory Medicine (D.L.W.), and Office of Health Promotion Research, Department of Surgery (B.L.S.), University of Vermont Larner College of Medicine, Burlington, Vt; and Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Mass (N.K.S.).

Radiology
|October 19, 2021
PubMed

Related Concept Videos